Menu
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Buy Currently
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Sample Portfolio
Sample Portfolio Analysis
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Account Requirements
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
Municipal Bond Presentation
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Normally Buy
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF® Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
CVS Health Corp
(NY:
CVS
)
78.60
-2.76 (-3.39%)
Official Closing Price
Updated: 7:00 PM EST, Jan 16, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about CVS Health Corp
< Previous
1
2
3
4
5
6
7
8
9
...
64
65
Next >
Can CVS Health Maintain Its Growth Through the End of 2025?
↗
November 08, 2025
The company's prospects are looking up.
Via
The Motley Fool
U.S. Labor Market Flashes Warning Signs: A November 2025 Economic Crossroads
November 07, 2025
The U.S. labor market is signaling a significant shift as November 2025 draws to a close, presenting a complex picture of decelerating job growth, a concerning surge in layoffs, and weakening consumer...
Via
MarketMinute
Topics
Artificial Intelligence
Bonds
Economy
Humana Faces Steep Decline Amidst Broad Market Downturn: A Look at Potential Triggers and Industry Repercussions
November 06, 2025
November 6, 2025 – Humana Inc. (NYSE: HUM) shares experienced a significant downturn today, mirroring a broader negative trend across the market. While specific real-time triggers for this hypothetical...
Via
MarketMinute
Earnings Scheduled For October 29, 2025
↗
October 29, 2025
Via
Benzinga
CVS, UnitedHealth, Elevance, Humana Gain Price Target Hikes Wall Street After Medicare Star Ratings Update
↗
October 09, 2025
Via
Stocktwits
5 Revealing Analyst Questions From CVS Health’s Q3 Earnings Call
November 05, 2025
CVS Health’s third quarter was shaped by strong top-line momentum across its core businesses, notably pharmacy and health insurance, with management attributing results to improved execution in retail...
Via
StockStory
Topics
Earnings
What the Options Market Tells Us About CVS Health
↗
October 31, 2025
Via
Benzinga
Why CVS Health (CVS) Stock Is Falling Today
October 30, 2025
Shares of diversified healthcare company CVS Health (NYSE:CVS) fell 4.3% in the morning session after the company reported a significant $5.7 billion goodwill impairment charge related to its Health...
Via
StockStory
Topics
Artificial Intelligence
CVS Q3 Deep Dive: Pharmacy Gains, Aetna Turnaround, and PBM Transition Shape Outlook
October 30, 2025
Diversified healthcare company CVS Health (NYSE:CVS) beat Wall Street’s revenue expectations in Q3 CY2025, with sales up 7.8% year on year to $102.9 billion. Its non-GAAP profit of $1.61 per share was...
Via
StockStory
CVS Health Delivers Confident Outlook After Q3 Performance, Stock Hits 52-Week High
↗
October 29, 2025
CVS Health topped Q3 estimates with $102.9 billion in revenue and raised its 2025 EPS outlook to up to $6.65 amid strong segment growth.
Via
Benzinga
CVS Health Corp (NYSE:CVS) Q3 2025 Earnings Top Estimates, Raises Full-Year Outlook
↗
October 29, 2025
CVS Health Q3 2025 earnings smash estimates with record revenue of $102.9B and EPS of $1.60. The company also raises its full-year profit outlook.
Via
Chartmill
CVS Health (NYSE:CVS) Delivers Strong Q3 Numbers
October 29, 2025
Diversified healthcare company CVS Health (NYSE:CVS) reported revenue ahead of Wall Streets expectations in Q3 CY2025, with sales up 7.8% year on year to $102.9 billion. Its non-GAAP profit of $1.60...
Via
StockStory
S&P 500 Tops 6,900 Ahead Fed Rate Move, Gold Reclaims $4,000: What's Moving Markets Wednesday?
↗
October 29, 2025
A powerful surge in AI-related stocks — led by a 9% advance in NVIDIA Corp. (NASDAQ:NVDA) over the past two sessions — propelled the S&P 500 above the 6,900 mark and lifted the Nasdaq 100 to 26,100...
Via
Benzinga
Topics
Economy
Stocks
Insights Ahead: CVS Health's Quarterly Earnings
↗
October 28, 2025
Via
Benzinga
Earnings To Watch: CVS Health (CVS) Reports Q3 Results Tomorrow
October 27, 2025
Diversified healthcare company CVS Health (NYSE:CVS) will be reporting results this Wednesday before market hours. Here’s what investors should know.
Via
StockStory
Topics
Artificial Intelligence
Inflation Vs. Reality: Bilello Slams 'Clearly Wrong' Government Data Claiming Health Insurance Prices Fell 18%—Costs 'Only Go In One Direction'
↗
October 27, 2025
Charlie Bilello slams "absurd" gov't data claiming health insurance fell 18%. He says costs "only go in one direction."
Via
Benzinga
Topics
Economy
What Does the Market Think About CVS Health Corp?
↗
October 21, 2025
Via
Benzinga
EMD Serono, CVS Health To Partner On TrumpRx Fertility Program Launching In 2026
↗
October 17, 2025
Trump and EMD Serono strike a deal to cut fertility drug costs, expand U.S. manufacturing, and launch the TrumpRx Fertility program in 2026.
Via
Benzinga
Topics
Government
CVS INVESTIGATION: Bragar Eagel & Squire, P.C. Continues Investigation into CVS Health Corporation on Behalf of Long-Term Stockholders and Urges Investors to Contact the Firm
October 16, 2025
From
Bragar Eagel & Squire
Via
GlobeNewswire
The Pharmacy Stock That's Cheaper Than It Should Be
↗
October 15, 2025
The company has crushed the market this year and still looks like a steal.
Via
The Motley Fool
1 Healthcare Stock to Research Further and 2 We Find Risky
October 14, 2025
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But speed bumps such as inventory destockings have persisted in the wake of COVID-19,...
Via
StockStory
Topics
Stocks
CVS Health Corp (NYSE:CVS) Shows Strong Technicals and Bullish Setup for Breakout
↗
October 11, 2025
CVS stock shows strong technical momentum and a high-quality breakout setup, offering a potential entry point for traders.
Via
Chartmill
1 Unpopular Stock That Deserves Some Love and 2 Facing Challenges
October 10, 2025
When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fear their firms will lose out in other...
Via
StockStory
Stocks Tumble As Trump Mulls 'Massive' China Tariffs: What's Moving Markets Friday?
↗
October 10, 2025
The stock market stumbled Friday after President Donald Trump threatened a sweeping increase in tariffs on Chinese imports, sending equity indices and risk sentiment sharply lower. • AMD shares are...
Via
Benzinga
Topics
Government
World Trade
Deal Dispatch: Confluent Considers Sale, Rothschild Exits The Economist, CVS Feels The Pain
↗
October 10, 2025
Confluent explores a sale, Rothschild exits The Economist, Helsing buys Blue Ocean, Zimmer expands robotics, and Omnicare files bankruptcy.
Via
Benzinga
Friday's pre-market session: top gainers and losers in the S&P500 index
↗
October 10, 2025
As we await the opening of the US market on Friday, let's delve into the pre-market session and discover the S&P500 top gainers and losers shaping the early market sentiment.
Via
Chartmill
Assessing CVS Health: Insights From 10 Financial Analysts
↗
October 09, 2025
Via
Benzinga
Amazon's Dual Thrust: Prime Discounts and Pharmacy Expansion Reshape Retail and Healthcare Landscapes
October 08, 2025
Amazon (NASDAQ: AMZN) continues to aggressively expand its strategic business developments, solidifying its e-commerce dominance through frequent Prime discount events and making significant inroads...
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Humana (HUM) Soars 11.9% Amidst Strong Market Confidence
October 03, 2025
Louisville, KY – October 3, 2025 – Humana Inc. (NYSE: HUM) witnessed a significant surge in its stock price today, jumping an impressive 11.9% in early trading. This substantial gain has positioned the...
Via
MarketMinute
Federal Shutdown Paralysis: Data Delays Deepen Economic Damage Fears
October 02, 2025
The United States economy finds itself navigating treacherous waters as a federal government shutdown grips the nation, sparking heightened concerns about widespread economic damage. What makes this...
Via
MarketMinute
Topics
Economy
Initial Public Offering
Regulatory Compliance
< Previous
1
2
3
4
5
6
7
8
9
...
64
65
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.